Comparative Analysis of Laboratory-Scale Immunoglobulin G Purification Methods from Human Serum.

GeLC-MS/MS IgG purification autoantibodies autoimmunity avidity immunoglobulin G (IgG) purity

Journal

Journal of proteome research
ISSN: 1535-3907
Titre abrégé: J Proteome Res
Pays: United States
ID NLM: 101128775

Informations de publication

Date de publication:
14 Aug 2024
Historique:
medline: 14 8 2024
pubmed: 14 8 2024
entrez: 14 8 2024
Statut: aheadofprint

Résumé

Immunoglobulin G (IgG) purification is a critical process for evaluating its role in autoimmune diseases, which are defined by the occurrence of autoantibodies. Affinity chromatography with protein G is widely considered to be the optimal technique for laboratory-scale purification. However, this technique has some limitations, including the exposure of IgG to low pH, which can compromise the quality of the purified IgG. Here, we show that alternative methods for IgG purification are possible while maintaining the quality of IgG. Different techniques for IgG purification from serum were evaluated and compared with protein G-based approaches: Melon Gel, caprylic acid-ammonium sulfate (CAAS) precipitation, anion-exchange chromatography with diethylamino ethyl (DEAE) following ammonium sulfate (AS) precipitation, and AS precipitation alone. The results demonstrated that the purification yield of these techniques surpassed that of protein G. However, differences in the purity of IgG were observed using GeLC-MS/MS. The avidity of purified IgG against selected targets (SARS-CoV-2 and topoisomerase-I) was similar between purified IgG obtained using all techniques and unpurified sera. Our work provides valuable insights for future studies of IgG function by recommending alternative purification methods that offer advantages in terms of yield, time efficiency, cost-effectiveness, and milder pH conditions than protein G.

Identifiants

pubmed: 39140748
doi: 10.1021/acs.jproteome.4c00268
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Louisa Bourel (L)

Univ. Lille, Inserm, CHU Lille, U1286-INFINITE─Institute for Translational Research in Inflammation, 59000 Lille, France.

Fabrice Bray (F)

Univ. Lille, CNRS, UAR 3290 - MSAP - Miniaturisation pour la Synthèse, l'Analyse et la Protéomique, F-59000 Lille, France.

Solange Vivier (S)

Univ. Lille, Inserm, CHU Lille, U1286-INFINITE─Institute for Translational Research in Inflammation, 59000 Lille, France.

Stéphanie Flament (S)

Univ. Lille, CNRS, UAR 3290 - MSAP - Miniaturisation pour la Synthèse, l'Analyse et la Protéomique, F-59000 Lille, France.

Lucile Guilbert (L)

Univ. Lille, Inserm, CHU Lille, U1286-INFINITE─Institute for Translational Research in Inflammation, 59000 Lille, France.
CHU Lille, Institut d'Immunologie, Centre de Biologie Pathologie, 59000 Lille, France.

Aurélien Chepy (A)

Univ. Lille, Inserm, CHU Lille, U1286-INFINITE─Institute for Translational Research in Inflammation, 59000 Lille, France.
CHU Lille, Département de Médecine Interne Et Immunologie Clinique, Centre de référence des Maladies Auto-Immunes et Auto-inflammatoires Systémiques rares de l'Adulte du Nord, Nord-Ouest, Méditerranée et Guadeloupe (CeRAINOM), 59000 Lille, France.

Christian Rolando (C)

Univ. Lille, CNRS, UAR 3290 - MSAP - Miniaturisation pour la Synthèse, l'Analyse et la Protéomique, F-59000 Lille, France.
Shrieking Sixties, 1-3 Allée Lavoisier, F-59650 Villeneuve-d'Ascq, France.

David Launay (D)

Univ. Lille, Inserm, CHU Lille, U1286-INFINITE─Institute for Translational Research in Inflammation, 59000 Lille, France.
CHU Lille, Département de Médecine Interne Et Immunologie Clinique, Centre de référence des Maladies Auto-Immunes et Auto-inflammatoires Systémiques rares de l'Adulte du Nord, Nord-Ouest, Méditerranée et Guadeloupe (CeRAINOM), 59000 Lille, France.

Sylvain Dubucquoi (S)

Univ. Lille, Inserm, CHU Lille, U1286-INFINITE─Institute for Translational Research in Inflammation, 59000 Lille, France.
CHU Lille, Institut d'Immunologie, Centre de Biologie Pathologie, 59000 Lille, France.

Vincent Sobanski (V)

Univ. Lille, Inserm, CHU Lille, U1286-INFINITE─Institute for Translational Research in Inflammation, 59000 Lille, France.
CHU Lille, Département de Médecine Interne Et Immunologie Clinique, Centre de référence des Maladies Auto-Immunes et Auto-inflammatoires Systémiques rares de l'Adulte du Nord, Nord-Ouest, Méditerranée et Guadeloupe (CeRAINOM), 59000 Lille, France.
Institut Universitaire de France (IUF), 75005 Paris, France.

Classifications MeSH